| Indicator available | |
|---|---|
| Indicator description | |
| Geographical coverage | |
| Unit of measurement | |
| Definitions | |
| Calculations | |
| Other information | |
| Quality assurance | |
| Comparability with international data/standards | |
| Comments and limitations | |
| Rational and interpretation | |
| Data last updated | 2024-09-25: see changes on GitHub opens in a new window |
| Metadata last updated | 2024-09-25: see changes on GitHub opens in a new window |
This table provides information on metadata for SDG indicators as defined by the UN Statistical Commission. Complete global metadata is provided by the UN Statistics Division.
| Indicator name |
Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis |
|---|---|
| Indicator number |
3.b.3 |
| Target name |
Support the research and development of vaccines and medicines for the communicable and non‐communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all |
| Target number |
3.b |
| Global indicator description | |
| UN designated tier |
3 |
| UN custodian agency |
WHO |
| Link to UN metadata |